137.64
Davita Inc (DVA) 最新ニュース
Palmetto Grain Brokerage - Palmetto Grain Brokerage
DaVita Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call - TradingView
2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid - The Motley Fool
DaVita Dipped 6% After Big Run-Up: Why Analysts See a Path to $210 in 2026 - TIKR.com
DaVita (DVA) Surges as Top Healthcare Gainer in S&P 500 - GuruFocus
DaVita (DVA) Is Up 28.8% After Strong 2026 Guidance And Heavy BuybacksWhat's Changed - simplywall.st
Guidance Update: Will DaVita Inc stock benefit from M AMarket Risk Report & Weekly Chart Analysis and Guides - baoquankhu1.vn
DaVita, Elara deal could signal new take on kidney, home care - Modern Healthcare News
Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely - simplywall.st
DaVita Inc. $DVA Shares Sold by Allianz Asset Management GmbH - MarketBeat
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita Inc. (NYSE:DVA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
DaVita Links IKC Profitability With Elara Home Care To Recast Growth - Yahoo Finance
DaVita (DVA) Margin Compression To 5.3% Challenges Bullish Valuation Narratives - Sahm
Here's why you should hold DaVita stock in your portfolio for now - MSN
DaVita stock price pops again as 2026 outlook fuels fresh Wall Street targets - TechStock²
UBS Raises Price Target for DaVita (DVA) to $190, Maintains Buy Rating | DVA Stock News - GuruFocus
DaVita Projects Significant EPS Growth Amid Strategic Expansion - StocksToTrade
DaVita stock price target raised to $190 from $186 at UBS on growth outlook - Investing.com Australia
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and DaVita (DVA) - The Globe and Mail
Lawsuit Investigation: Did DaVita Violate Patients’ Online Privacy? - ClassAction.org
Why Is DaVita (DVA) Stock Rocketing Higher Today - The Globe and Mail
DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression - The Globe and Mail
Dallas Team Featured as Litigator of the Week - Winston & Strawn
Research Alert: CFRA Maintains Hold View On Shares Of Davita Inc. - 富途牛牛
Is DaVita stock underperforming the Dow? - MSN
Ares, DaVita to invest in home health provider Elara Caring By Investing.com - Investing.com India
DaVita Home Care Partnership Puts Valuation And Risk Profile In Focus - Sahm
DaVita’s Q4 Earnings Triumph Sparks Market Interest - timothysykes.com
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Shares Surge on Strong Q4 Results and Optimistic 20 - GuruFocus
DaVita Stock Surges as Q4 Earnings Exceed Expectations - StocksToTrade
DaVita Celebrates Strong Earnings as Strategic Investments Boost Future Outlook - timothysykes.com
Ares, DaVita Make Strategic Investment in Elara Caring - Hospice News
DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale - Seeking Alpha
Explore DaVita Within Dow Jones Industrial Average Healthcare Space - Kalkine Media
DaVita (DVA) Shares Surge Over 21% Amid Market Moves - GuruFocus
DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next - TechStock²
What Sent DaVita Stock Soaring On Tuesday? - Finviz
DaVita Inc Stock Soars 25% After DaVita Beats Q4 Results And Raises 2026 Outlook - Nasdaq
DaVita Stock Rallies On Profit Beat, Confident 2026 View - Benzinga
DaVita Stock Soars as Q4 Earnings and Strategy Surpass Expectations - StocksToTrade
Silver Surges Over 15%; Pfizer Earnings Top Views - Benzinga
Short Interest in DaVita Inc. (NYSE:DVA) Decreases By 14.2% - MarketBeat
DaVita’s Remarkable Financial Surge Surpasses Analysts’ Expectations - timothysykes.com
TD Cowen reiterates Hold rating on DaVita stock with $133 price target - Investing.com
DaVita (DVA) Soars Over 23% Amid Positive Market Movement - GuruFocus
DaVita: Some Success Is Possible, But Volatility Is Still Heavy (NYSE:DVA) - Seeking Alpha
DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand - Yahoo Finance
DaVita (NYSE:DVA) Shares Gap Up After Earnings Beat - MarketBeat
Davita Posts Upbeat Q4 Earnings, Joins Woodward, Terawulf And Other Big Stocks Moving Higher On Tuesday - Benzinga
Barclays Raises Price Target for DaVita (DVA) to $158 | DVA Stoc - GuruFocus
DaVita Q4 Revenue Up 10%; Announces Strategic Investment In Elara Caring - Nasdaq
DaVita Inc. (NYSE:DVA) Q4 2025 Earnings Call Transcript - Insider Monkey
DaVita rises on upbeat annual profit forecast - TradingView
Barclays Adjusts Price Target on DaVita to $158 From $143 - marketscreener.com
Is DaVita (DVA) Offering Value After A 37% One-Year Share Price Decline? - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Buys 11,718 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Stock Pre-Market (+14%): Stellar Q4 Earnings and Aggressive 2026 Guidance - Trefis
DaVita Inc (DVA) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
DaVita Inc (DVA) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges By GuruFocus - Investing.com Canada
Why Did DaVita Stock Jump 15% After Hours Today? - Asianet Newsable
DaVita Q4 2025 Results: Revenue Beat, Profit Growth, and 2026 OutlookNews and Statistics - IndexBox
大文字化:
|
ボリューム (24 時間):